NCT02233608

Brief Summary

Radical prostatectomy is a common and effective treatment for prostate cancer but is associated with urinary incontinence that can persist for several months after surgery and significantly reduce quality of life. Studies have shown that routine performance of pelvic floor exercises after radical prostatectomy can aid in the recovery of urinary control; however, conventional pelvic floor exercises do not produce consistent results. Research indicates that incorporating other deep abdominal muscles can further activate the pelvic floor making it stronger than by activating the pelvic floor alone. Specifically, 'Pfilates' and 'Hypopressives' are two new techniques that combine traditional pelvic floor exercises with activation of supportive muscles. Our proposed study will be the first to test the effect of an advanced pelvic floor exercise training program that includes Pfilates and Hypopressives to treat urinary incontinence following radical prostatectomy. Our primary aim of this study is to assess the feasibility of conducting a full-scale RCT of an advanced pelvic floor exercise training program, including standard pelvic floor exercises, Pfilates, and Hypopressives techniques on urinary incontinence. Feasibility will be determined by measuring recruitment success, retention, outcome capture, and intervention adherence, tolerance, and safety. We hypothesize men under going radical prostatectomy for prostate cancer in the advance pelvic floor training program will report greater improvement in urinary incontinence and health-related quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
88

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Jan 2015

Typical duration for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 3, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 8, 2014

Completed
4 months until next milestone

Study Start

First participant enrolled

January 1, 2015

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 28, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 28, 2017

Completed
Last Updated

October 26, 2017

Status Verified

October 1, 2017

Enrollment Period

2.7 years

First QC Date

September 3, 2014

Last Update Submit

October 24, 2017

Conditions

Keywords

Prostate cancerRadical prostatectomyPelvic floor muscle exercisesPfilatesHypopressivesUrinary Incontinence

Outcome Measures

Primary Outcomes (5)

  • Recruitment

    Prior pelvic floor training trials in prostate cancer patients undergoing radical prostatectomy have observed recruitment rates of 21-70%. We will measure recruitment success through participant recruitment per week and record reasons for non-participation from those who inquire about the study and are eligible to participate but refuse.

    When recruitment is complete (approximately 12 months after study initiation; October 2015)

  • Adherence to intervention group

    Adherence to the two groups (standard pelvic floor exercises and advanced pelvic floor exercises) will be measured through a logbook that is included in their respective program manuals as well as a logbook completed by the research coordinator during the weekly telephone communications.

    26 weeks post-operatively

  • Study retention

    Retention will be assessed by measuring attrition throughout the intervention period and at each assessment.

    26 weeks post-operative

  • 24-hour Pad Test for Urinary Leakage

    A 24-hour pad test will be used to measure urinary incontinence by assessing the quantity of urine lost in one day. A urinary leakage pad is measured after a 24-hour period and compared to the unused pad weight and is used to most accurately assess the severity of urinary incontinence.

    At baseline, approximately 1 week prior to surgery, and 2, 6, 12, 26 weeks post-operatively

  • Pelvic Floor Strength

    Digital rectal examination of pelvic floor strength by a specially trained pelvic floor physiotherapist will be conducted. Pelvic floor strength will be graded on the Modified Oxford Scale.

    At baseline, approximately 1 week prior to surgery, and 2, 6, 12, 26, weeks post-operatively

Secondary Outcomes (5)

  • Quality of Life

    At baseline, approximately 1 week prior to surgery, and 2, 6, 12, 26 weeks post-operative

  • 3-Day Bladder Diary for Urinary Incontinence

    At baseline, approximately 1 week prior to surgery, and 2, 6, 12, 26 week post-operatively

  • Self-Reported Urinary Incontinence, Prostate Symptoms, and Erectile Function

    At baseline, approximately 1 week prior to surgery, and 2, 6, 12, 26 week post-operatively

  • Body Composition

    At baseline, approximately 1 week prior to surgery, and 2, 6, 12, 26 week post-operatively

  • Physical Activity

    At baseline, approximately 1 week prior to surgery, and 2, 6, 12, 26 weeks post-operatively

Study Arms (2)

Usual Care

NO INTERVENTION

The usual care group will receive generic pelvic floor muscle exercise (PMFX) instructions and demonstrations by the research coordinator at the initial post-operative time point. This will include instruction on how to engage the pelvic floor and specific PFMX prescription. Repetition volume will start at 20 repetitions per day during weeks 1-2; 60/day during weeks 3-4; and 90/day during weeks 5-6, and 100+/day for weeks 7-26. The total number of repetitions will be divided equally between rhythmic (contract and relaxed over one second) and sustained contractions (contract and hold for up to 10 seconds).

Advanced Pelvic Floor Exercise (APFX)

EXPERIMENTAL

Participants in this group will receive detailed week-by-week description of the program. The program progresses participants through stages of training every two weeks, starting the introduction of basic PFMX, and slowly incorporates Pfilates and Hypopressives exercises until week 8, where patients will maintain the final stage of training until week 26 or urinary incontinence is completely resolved.

Behavioral: Advanced Pelvic Floor Muscle Exercise (APFX)

Interventions

Advanced Pelvic Floor Exercise (APFX)

Eligibility Criteria

Age40 Years - 80 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men with localized prostate cancer (stage cT1-cT2) who have consented for radical prostatectomy (open retropubic, laparoscopic, robot-assisted laparoscopic)
  • Between the the ages of 40 and 80 years
  • Proficient in English

You may not qualify if:

  • i) Diagnosed with a known neurological disease, autoimmune connective tissue disorder;
  • ii) Have prior experience with pelvic floor training by a healthcare provider;
  • iii) Have uncontrolled hypertension;
  • iv) Have diagnosed COPD (Chronic Obstructive Pulmonary Disease) and/or chronic restrictive respiratory disease; or
  • v) Have a history of inguinal herniation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Health Network

Toronto, Ontario, M5G 2C4, Canada

Location

Related Publications (1)

  • Santa Mina D, Au D, Alibhai SM, Jamnicky L, Faghani N, Hilton WJ, Stefanyk LE, Ritvo P, Jones J, Elterman D, Fleshner NE, Finelli A, Singal RK, Trachtenberg J, Matthew AG. A pilot randomized trial of conventional versus advanced pelvic floor exercises to treat urinary incontinence after radical prostatectomy: a study protocol. BMC Urol. 2015 Sep 16;15:94. doi: 10.1186/s12894-015-0088-4.

MeSH Terms

Conditions

Prostatic NeoplasmsUrinary Incontinence

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital DiseasesUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Scientist

Study Record Dates

First Submitted

September 3, 2014

First Posted

September 8, 2014

Study Start

January 1, 2015

Primary Completion

September 28, 2017

Study Completion

September 28, 2017

Last Updated

October 26, 2017

Record last verified: 2017-10

Locations